Key facts
- Patient safety commissioner Dr. Henrietta Hughes is urging the government to provide swift financial assistance to victims of the sodium valproate and pelvic mesh scandals.
- The valproate scandal has affected an estimated 20,000 children exposed to the drug in the womb, leading to neurodevelopmental disorders.
- Thousands of women have suffered life-changing complications from pelvic mesh implants, including severe pain and loss of mobility.
- Dr. Hughes recommended initial payments of £100,000 for valproate victims and £20,000 for mesh victims, followed by further aid.
- Campaigners criticize the government's lack of action and commitment to compensation as 'morally unacceptable'.
England's patient safety commissioner, Dr. Henrietta Hughes, has urged the government to act swiftly to provide financial assistance and justice to victims of the sodium valproate and pelvic mesh scandals. A review found that lives were ruined because the healthcare system failed to listen to concerns about these treatments.
Sodium valproate is an effective epilepsy and bipolar disorder medication, but it can cause severe birth defects, including neurodevelopmental disorders like autism, if taken during pregnancy. Scientific papers as early as the 1980s suggested the drug's dangers, yet warnings were not added to some packaging until 2016. An estimated 20,000 children were exposed to the drug in the womb.
Pelvic mesh implants, once considered a standard treatment for incontinence and prolapse in women, can erode and cause significant pain and life-altering complications. Thousands of women have experienced loss of mobility, relationships, and employment due to these issues. Figures suggest over 127,000 mesh implants were used for incontinence and pelvic organ prolapse between April 2008 and March 2017, though campaigners believe the actual number is higher.
Dr. Hughes recommended initial payments of £100,000 for victims of the sodium valproate scandal and £20,000 for women injured by pelvic mesh implants. These initial payments should be followed by further financial and non-financial assistance. She described the sodium valproate scandal as potentially "bigger than thalidomide" and stated that a redress scheme is a 'question of justice' for families who have been fighting for decades.
Campaigners have expressed frustration and anger over the government's continued inaction, calling the failure to provide compensation 'morally unacceptable' and 'insulting.' They highlight the severe mental health toll and financial hardship faced by affected individuals and families. The government has acknowledged the findings but stated there is currently no timetable for compensation. Dr. Hughes has pledged to escalate the matter to the prime minister.